ArticleThe journal of allergy and clinical immunology. In practice2021
A Scoping Review of International Barriers to Asthma Medication Adherence Mapped to the Theoretical Domains Framework.
Article in The journal of allergy and clinical immunology. In practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Challenges in translating GINA asthma recommendations into practice: a qualitative study of healthcare professionals in Jordan.BMJ open · 2026Article
- Psychological and Related Factors Influencing Adherence to Biologic Therapies in Asthma: A Scoping Review.Current allergy and asthma reports · 2025Article
- Selection of Behavior Change Techniques for Asthma Medication Adherence Apps: Evidence-Based Design Study.JMIR mHealth and uHealth · 2025Article
- Identifying and presenting key country-specific indicators related to medication adherence: a comprehensive study across European countries.Frontiers in pharmacology · 2024Article
- The Interaction Between Asthma, Emotions, and Expectations in the Time of COVID-19.Journal of asthma and allergy · 2023Article
- Breaking the vicious circle-the Asthma Referral Identifier (ReferID) tool.NPJ primary care respiratory medicine · 2022Review
- Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China.Frontiers in pharmacology · 2022Article
- Asthma and COVID-19: a systematic review.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021Article
- A Targeted Approach to Improve Asthma Control Using Community Pharmacists.Frontiers in pharmacology · 2021Article
- Barriers and facilitators to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis protocol.HRB open research · 2021Article
- Medication Adherence in a Community Population with Uncontrolled Asthma.Pharmacy (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundInternationally, adult asthma medication adherence rates are low. Studies characterizing variations in barriers by country are lacking.
objectiveTo conduct a scoping review to characterize international variations in barriers to asthma medication adherence among adults.
methodsMEDLINE, EMBASE, Web of Science (WOS), and CINAHL were searched from inception to February 2017. English-language studies employing qualitative methods (eg, focus groups, interviews) were selected to assess adult patient- and/or caregiver-reported barriers to asthma medication adherence. Two investigators independently identified, extracted data, and collected study characteristics, methodologic approach, and barriers. Barriers were mapped using the Theoretical Domains Framework and findings categorized according to participants' country of residence, countries' gross national income, and the presence of universal health care (World Health Organization definitions).
resultsAmong 2942 unique abstracts, we reviewed 809 full texts. Among these, we identified 47 studies, conducted in 12 countries, meeting eligibility. Studies included a total of 2614 subjects, predominately female (67%), with the mean age of 19.1 to 70 years. Most commonly reported barriers were beliefs about consequences (eg, medications not needed for asthma control, N = 29, 61.7%) and knowledge (eg, not knowing when to take medication, N = 27, 57.4%); least common was goals (eg, asthma not a priority, N = 1, 2.1%). In 27 studies conducted in countries classified as high income (HIC) with universal health care (UHC), the most reported barrier was participants' beliefs about consequences (N = 17, 63.3%). However, environmental context and resources (N = 12, 66.7%) were more common in HIC without UHC.
conclusionInternational adherence barriers are diverse and may vary with a country's sociopolitical context. Future adherence interventions should account for trends.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.